D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
1376
DELISTED
Exact Sciences
EXAS
| $8.42M | 0.01% |
121,874
+99,127
| +436% | +$6.27M |
|
1377
John Wiley & Sons Class A
WLY
$2.65B
| $8.41M | 0.01% |
220,444
| – | – |
|
1378
Crown Holdings
CCK
$12.8B
| $8.4M | 0.01% |
+105,993
| New | +$8.68M |
|
1379
Usana Health Sciences
USNA
$408M
| $8.4M | 0.01% |
173,209
+6,206
| +4% | +$304K |
|
1380
Badger Meter
BMI
$3.89B
| $8.38M | 0.01% |
51,785
+479
| +0.9% | +$73.6K |
|
|
CTRA
1381
DELISTED
Coterra Energy
CTRA
| $8.38M | 0.01% |
300,507
-1,023,410
| -77% | -$26.2M |
|
1382
Gates Industrial Corporation Ltd.
GTES
$7.13B
| $8.33M | 0.01% |
470,191
+104,117
| +28% | +$1.51M |
|
1383
CALL
Diamondback Energy
FANG
$57.1B
| $8.32M | 0.01% |
42,000
-22,700
| -35% | -$3.85M |
|
|
WBA
1384
DELISTED
Walgreens Boots Alliance
WBA
| $8.32M | 0.01% |
383,474
+328,703
| +600% | +$7.3M |
|
1385
Kura Oncology
KURA
$794M
| $8.32M | 0.01% |
389,902
+184,282
| +90% | +$3.58M |
|
1386
Cloudflare
NET
$99.1B
| $8.31M | 0.01% |
85,772
-90,878
| -51% | -$8.23M |
|
1387
PUT
Antero Resources
AR
$11.1B
| $8.3M | 0.01% |
286,100
-174,100
| -38% | -$4.2M |
|
1388
Pennant Group
PNTG
$1.41B
| $8.28M | 0.01% |
421,830
+6,814
| +2% | +$115K |
|
1389
Lemonade
LMND
$3.8B
| $8.25M | 0.01% |
502,795
+98,230
| +24% | +$1.65M |
|
1390
Independent Bank
INDB
$3.98B
| $8.22M | 0.01% |
+157,993
| New | +$8.73M |
|
1391
Bread Financial
BFH
$4.35B
| $8.21M | 0.01% |
220,486
-114,640
| -34% | -$4.07M |
|
|
AVNS
1392
DELISTED
Avanos Medical
AVNS
| $8.2M | 0.01% |
411,780
+77,663
| +23% | +$1.5M |
|
1393
World Kinect Corp
WKC
$2.02B
| $8.2M | 0.01% |
309,874
+19,844
| +7% | +$471K |
|
|
SILV
1394
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $8.19M | 0.01% |
1,229,270
-13,246
| -1% | -$77.4K |
|
1395
CALL
Sun Life Financial
SLF
$46.1B
| $8.19M | 0.01% |
150,000
+55,000
| +58% | +$2.91M |
|
|
ANSC
1396
Agriculture & Natural Solutions Acquisition Corp
ANSC
| $8.17M | 0.01% |
+804,500
| New | +$8.15M |
|
1397
Gildan
GIL
$10.3B
| $8.16M | 0.01% |
219,787
-136,890
| -38% | -$4.65M |
|
1398
CALL
Constellation Brands
STZ
$22.2B
| $8.15M | 0.01% |
30,000
| – | – |
|
1399
iShares MSCI United Kingdom ETF
EWU
$4.15B
| $8.15M | 0.01% |
+238,296
| New | +$7.82M |
|
1400
Replimune Group
REPL
$913M
| $8.15M | 0.01% |
997,786
+754,780
| +311% | +$6.19M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Arm worth $297M.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.